Acadia Pharmaceuticals (ACAD) Price to Sales (2011 - 2026)
Acadia Pharmaceuticals' (ACAD) Price to Sales came in at 3.82 for Q2 2026, up 7.2% from 3.57 a year earlier and up 10.0% from the prior quarter.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Acadia Pharmaceuticals' Price to Sales stood at 4.25, up 32.9% from FY2024.
- In prior years, Acadia Pharmaceuticals' Price to Sales was 3.19 in FY2024 (-55.0%), 7.10 in FY2023 (+42.3%), 4.99 in FY2022 (-35.7%) and 7.76 in FY2021 (-59.8%).
- Quarterly Price to Sales has run from a low of 2.75 in Q3 2024 to a high of 7.93 in Q1 2022 over five years.
- On a year-over-year basis, Price to Sales has increased in each of the last five quarters, with an average decline of 2.7% over the last eight quarters.
- The strongest year-over-year quarter for Price to Sales in the past five years was Q2 2023, with growth of 59.6%; the weakest was Q3 2021, with a decline of 64.0%.
- According to Business Quant data, Price to Sales for the three prior quarters was 3.48 (Q1 2026), 4.25 (Q4 2025) and 3.45 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn |
| 10 | Acadia Pharmaceuticals | 3.39 Bn | -84.62 Mn | 279.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.82 |
| Mar 31, 2026 | 3.48 |
| Dec 31, 2025 | 4.25 |
| Sep 30, 2025 | 3.45 |
| Jun 30, 2025 | 3.57 |
| Mar 31, 2025 | 2.79 |
| Dec 31, 2024 | 3.19 |
| Sep 30, 2024 | 2.75 |
| Jun 30, 2024 | 3.03 |
| Mar 31, 2024 | 3.75 |
| Dec 31, 2023 | 7.10 |
| Sep 30, 2023 | 5.41 |
| Jun 30, 2023 | 7.10 |
| Mar 31, 2023 | 5.87 |
| Dec 31, 2022 | 4.99 |
| Sep 30, 2022 | 5.18 |
| Jun 30, 2022 | 4.45 |
| Mar 31, 2022 | 7.93 |
| Dec 31, 2021 | 7.76 |
| Sep 30, 2021 | 5.63 |
API Access
Acadia Pharmaceuticals Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();